Wednesday, 28 September, 2022

Topic: Pfizer

Moderna sues Pfizer, BioNTech for infringing its Covid vaccine patent

The company said the rival vaccine makers breached patents that covered its ‘foundational mRNA technology’.

Pfizer’s Covid vaccine safe & effective for children under 5, says US FDA

A lower rate of adverse reactions was seen in trials of the youngest kids, compared with trials of older age groups, the Food and Drug Administration (FDA) report said.

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Pfizer’s combo drug Paxlovid could reduce risk of severe Covid by 89%, shows trial in US

Pfizer researchers conducted phase 2/3 clinical trial among unvaccinated Covid patients who had symptoms but weren’t in hospital, and were at high risk of disease becoming severe.

Pfizer begins making hybrid Covid vaccine that targets Omicron & original virus

Pfizer will evaluate the new formulation against an Omicron-specific shot, and determine which is best suited to move forward by March, the drug giant’s CEO Albert Bourla said.

US clears Merck’s Covid pill as it weighs how to ration Pfizer drug

Regulators are signaling they prefer Pfizer’s pill, which they’ve bought more of, but the US will have a lot more early on of Merck’s pill, which is 'better' than no treatment.

Booster dose of 6 Covid vaccines is safe, increases immunity, shows study in Lancet

The study looked at safety, immune response and side-effects of seven vaccines — Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva and Curevac.

Drug-resistant infections are becoming increasingly common. Here’s how we can fight it

The lack of appropriate access to medicines gives pathogens an opportunity to infect more people and develop resistance.

Pfizer asks US FDA to authorise Covid booster shots for all adults

Pfizer submitted data from a large trial showing that an additional dose is highly effective at preventing infection.

UK reduces booking time for Covid booster shots by a month to ramp up vaccine rollout

All aged above 50 years and those at most risk from Covid will be able to book their appointment after five months rather than waiting for six months.

On Camera


Congress leader Rahul Gandhi and Yogendra Yadav at the Bharat Jodo Yatra | YogendraYadav/Facebook

‘Congress must die’, I said in 2019. What I meant then, and what’s changed now

At this juncture in history, you don't hold on to grudges. Following Paul Samuelson, I ask everyone: 'When the situation changes, I change my assessment. What about you, sir?'
The logo of the Adani Group is seen on the facade of one of its buildings on the outskirts of Ahmedabad | Reuters file photo

From ports to energy transition — Adani Group to invest over $100 billion in next decade

Speaking at Forbes Global CEO Conference in Singapore, Adani said the group intends to do more as a solar player & has earmarked 70% of the investment for the energy transition space.


Parts of Iranian made 'suicide' drone Shahed-136 after being shot down by the Ukrainian military | Reuters

All about Shahed-136, Iran’s ‘kamikaze’ drone that Russia is using to strike Ukraine

Over the past few days, Russia has hit multiple targets using these Iranian-supplied drones—including civilian structures and amenities—leading to the death of several Ukrainians.
Illustration by Soham Sen | ThePrint

AAP’s filling a big vacuum in Indian politics. Question is how long it can sustain without ideology

If you find admiration for AAP qualified, if not muted among many of the Modi-BJP’s critics, it is because they question it for its lack of ideological clarity. Especially on secularism.